Full-Time

Senior Account Executive

Updated on 8/1/2026

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

Compensation Overview

$74k - $105.8k/yr

Remote in USA

Remote

Travel, including overnight travel, is required within the assigned customer base and geographic territory.

Category
Sales & Account Management (1)
Required Skills
Sales
Supply Chain Management
CRM
Financial analysis
Salesforce
Customer Service

Get referred to Cencora

See people who can refer or advise you

Requirements
  • Candidates must communicate effectively both orally and in writing.
  • Candidates must have excellent integration, implementation, and management skills.
  • Candidates must have excellent interpersonal skills.
  • Candidates must have working knowledge of computers necessary to operate effectively with company systems and programs.
  • Candidates must have excellent customer service skills to address potential issues through channels such as Customer Care without compromising a selling-focused conversation.
  • Candidates must have excellent follow-up skills to ensure practical follow-through.
  • Candidates must have strong presentation skills.
  • Candidates must have strong time management skills and the ability to schedule customer appointments and calls in advance.
  • Candidates must have an advanced understanding of financial concepts relevant to maximizing sales profit, including profit and loss statements and value.
  • Candidates must be able to work independently and demonstrate strong organizational skills as a self-starter.
  • Candidates must be willing to travel and attend client meetings, trade shows, and ABC meetings or training.
  • Candidates must have advanced working knowledge of the suite of ABC programs and solutions that can offer increased customer value and enhance customer stickiness.
  • Candidates must demonstrate strong organizational skills and attention to detail.
  • Candidates must be able to build strong in-person customer relationships.
  • Candidates must demonstrate good decision-making skills.
  • Candidates must have advanced knowledge of the hospital systems market.
  • Candidates must have strong consultative selling skills and sales analytical skills.
  • Candidates must demonstrate initiative in professional development and business curiosity by keeping abreast of the industry and its changes through industry information and company literature.
Responsibilities
  • Lead the client-facing relationship with all levels of pharmacy and supply chain contacts by leveraging active listening and advanced probing skills.
  • Promote and consultatively sell distribution and other solutions to expand business with existing health systems customers in a specific geographic area, and identify and bring on new business.
  • Demonstrate a deep understanding of client needs during conversations with economic influencers, pharmacy, supply chain, and the C-suite.
  • Own the renewal, new business, and request for proposal process, including identifying customer strategic priorities, developing proposals, pricing, negotiating deals to completion, and mitigating margin erosion.
  • Organize and ensure quarterly client business reviews that align with and address the client's strategic priorities.
  • Increase distribution business revenue and profit through account penetration and productive business relationships that identify opportunities and challenges addressable by company programs, solutions, and services.
  • Develop and maintain territory and account plans aligned with revenue, profitability, and sales goals.
  • Develop and deliver tailored, professional, and impactful presentations to existing customers using a consultative selling approach that articulates the value the company can provide.
  • Remain accountable for revenue and profitability objectives in assigned accounts and implement growth-driving opportunities for each client.
  • Engage and collaborate with internal resources during the sales process to execute sales expansion and maintenance strategies using services and solutions addressing customer-specific needs.
  • Identify potential new customers within the territory and work with subject matter experts to prospect account needs, design consultative sales strategies, secure requests for proposal, negotiate terms, and bring on new business.
  • Maintain and input account activity and results information and track interactions in Salesforce, Altify, and other appropriate sales or customer relationship management tools.
  • Manage the assigned territory with a regular call cycle that delivers defined customer touches while making discretionary calls when situations require.
  • Travel as required, including overnight travel, within the assigned customer base and geographic territory, and attend conferences and sales meetings.
  • Perform related duties as assigned.

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Get referred to Cencora

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Specialty drug growth lifts mix toward higher-value distribution and services.
  • More manufacturer outsourcing supports commercialization, access, and consulting revenue.
  • Pharmacy automation and reimbursement support can improve margins and customer retention.

What critics are saying

  • PBM-owned pharmacies and home-delivery channels compress Cencora's specialty distribution economics.
  • Generic deflation and customer consolidation pressure spreads in U.S. Healthcare Solutions.
  • Opioid litigation from AmerisourceBergen legacy still threatens cash and management attention.

What makes Cencora unique

  • Largest U.S. drug wholesaler with broad brand, generic, and specialty distribution.
  • International Healthcare Solutions adds global commercialization services beyond basic pharmaceutical distribution.
  • Animal health, patient access, and data analytics widen its service stack.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Company News

Yahoo Finance
Mar 23rd, 2026
Cencora buys EyeSouth Partners' retina business for $1.1B to expand Retina Consultants of America

Cencora has signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The affiliated retina physicians will join Cencora's Retina Consultants of America, a leading management services organisation. The pharmaceutical solutions company expects the acquisition to be slightly accretive to its adjusted diluted earnings per share in the first twelve months following closure, net of financing costs. The transaction requires regulatory approvals and customary closing conditions. Cencora's reaffirmed fiscal 2026 financial guidance does not currently include the transaction closing within that fiscal year. BofA Securities served as lead financial advisor to Cencora, whilst Jefferies advised EyeSouth Partners, a portfolio company of Olympus Partners.

The Associated Press
Mar 17th, 2026
Cencora CFO James Cleary to retire after eight years, search underway for successor

Cencora has announced that Chief Financial Officer James F. Cleary will retire effective 30 June 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates. Cleary, 62, has served as CFO since November 2018 and joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he had been chief executive officer for over a decade. He will serve in an advisory capacity through the end of 2026 to ensure a smooth transition. Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026. The company, ranked number 10 on the Fortune 500, generates more than $300 billion in annual revenue.

TradingView
Feb 11th, 2026
Cencora prices $3B senior notes offering across multiple maturities

Cencora has priced a $3 billion senior notes offering across various maturities, the company announced on 10 February 2026. No further details about the specific maturities, interest rates or intended use of proceeds were disclosed in the announcement.

Yahoo Finance
Feb 4th, 2026
Cencora raises fiscal 2026 guidance after completing OneOncology acquisition

Cencora reported 12% adjusted operating income growth and 9% adjusted diluted EPS growth in its fiscal 2026 first quarter, driven by its US healthcare solutions business. The company raised its full-year guidance to reflect year-over-year adjusted operating income growth of 11.5% to 13.5%. CEO Robert Mauch announced the completion of Cencora's acquisition of the majority remaining equity interest in OneOncology. The deal strengthens Cencora's specialty pharmaceutical leadership and MSO (management services organisation) platform. Cencora's strategy focuses on three priorities: strengthening leadership in specialty pharmaceuticals, partnering with market leaders, and enhancing patient access to pharmaceuticals. The company is leveraging technology and advanced analytics to improve customer experience and operational excellence whilst expanding its pharmaceutical-centric MSO footprint.

Yahoo Finance
Feb 4th, 2026
Cencora beats profit estimates on specialty drug demand, completes $5B OneOncology acquisition

Cencora beat Wall Street's first-quarter profit estimates on Wednesday, driven by sustained demand for specialty medicines and GLP-1 therapies. The drug distributor reported adjusted earnings of $4.08 per share, exceeding analysts' expectations of $4.04. The company completed its $5 billion acquisition of OneOncology from TPG in December, strengthening its presence in cancer care. It raised its fiscal 2026 adjusted operating income growth forecast to 11.5% to 13.5%, up from 8% to 10% previously. However, quarterly revenue of $85.93 billion fell short of expectations of $86.03 billion, sending shares down 5% in pre-market trading. Sales at its largest unit, US healthcare solutions, rose 5% year-over-year to $76.2 billion, boosted by prescription volumes of weight-loss drugs and specialty medicines.